DOCSLIB.ORG

Role of CHD7 in Neural Development and Maintenance by Wanda

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Role of CHD7 in Neural Development and Maintenance by Wanda Role of CHD7 in neural development and maintenance by Wanda Sherrie Layman A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Human Genetics) in The University of Michigan 2011 Doctoral Committee: Associate Professor Donna M. Martin, Chair Professor Sally A. Camper Professor Jeffrey W. Innis Professor Miriam H. Meisler Associate Professor Jeffrey R. Martens 1 © Wanda Sherrie Layman 2011 2 Dedication To my Bear and cub, with your love and support all things are possible… ii Acknowledgements First, I would like to thank Donna Martin for her mentorship and support. I have benefitted greatly from having you as my mentor. I would also like to thank the members of the Martin lab. Liz, you were definitely the best half of the CHD7 dynamic duo. I’m not sure I would have survived the last several years in the lab without you. Jennifer, Mindy, Jillian, and Joe – thank you for all of your help and support. I also need to thank Jeff Martens and some former members of the Martens lab, Dyke and Paul. When I first started this project, I knew absolutely nothing about olfaction or olfactory tissues. My thesis project was greatly influenced by your help and support. Many individuals contributed to making this work possible. I am grateful to the members of my thesis committee Sally Camper, Jeff Innis, Miriam Meisler, and Jeff Martens for their support and guidance. I could not have found better scientists and mentors to guide me through this project. Yehoash Raphael and the Raphael lab were also incredibly beneficial to this work. Thanks also to the Program in Biomedical Sciences (PIBS), the Human Genetics department, and the University of Michigan for taking on a graduate student that did not have the best grades, test scores, or experience. Finally, I would like to thank my family. Brian and Xavier, I don’t know how you put up with me all of these years, but I would never have continued on to this point in my life without both of you. Thank you Mom, words cannot express how much I respect iii and love you. Dad, I guess that I will finally be Dr. Wanda; I wish you could have lived to see it happen. iv Table of Contents ontents Dedication .......................................................................................................................... ii Acknowledgements .......................................................................................................... iii List of Figures ................................................................................................................. viii List of Tables ..................................................................................................................... x Abstract ............................................................................................................................. xi Chapter 1 Introduction....................................................................................................... 1 Abstract ........................................................................................................................... 1 Introduction ..................................................................................................................... 2 CHD7 mutations cause CHARGE syndrome ................................................................. 3 Mouse models of CHARGE and tissue specific defects ................................................. 4 Inner ear abnormalities in humans and mice with CHD7 deficiency ............................. 5 Impaired olfaction in humans and mice with CHD7 deficiency..................................... 6 CHD7 and other CHD proteins: classification and characteristics ................................. 9 CHD7 binding sites and interacting proteins ................................................................ 10 Summary and future studies.......................................................................................... 11 v Chapter 1 Notes............................................................................................................. 12 References ..................................................................................................................... 20 Chapter 2 Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome ............................... 35 Abstract ......................................................................................................................... 35 Introduction ................................................................................................................... 36 Results ........................................................................................................................... 38 Discussion ..................................................................................................................... 49 Materials & Methods .................................................................................................... 55 Chapter 2 Notes............................................................................................................. 63 References ..................................................................................................................... 75 Chapter 3 Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome .......................................................................................... 88 Abstract ......................................................................................................................... 88 Introduction ................................................................................................................... 89 Results ........................................................................................................................... 90 Discussion ................................................................................................................... 100 Materials and Methods ................................................................................................ 105 Chapter 3 Notes........................................................................................................... 112 References ................................................................................................................... 119 vi Chapter 4 CHD7 deficient mice have defects in neural stem cell maintenance and cell fate................................................................................................................................... 137 Introduction ................................................................................................................. 137 Results ......................................................................................................................... 139 Discussion ................................................................................................................... 143 Materials and Methods ................................................................................................ 145 References ................................................................................................................... 155 Chapter 5 Conclusion .................................................................................................... 164 CHD7 in olfactory tissues ........................................................................................... 164 CHD7 and reproductive dysfunction .......................................................................... 169 vii List of Figures Figure 1.1 Chd7 is expressed in CHARGE related tissues during development ............ 13 Figure 1.2 Model of inner ear development in wild type and Chd7 heterozygous mutant mice. .................................................................................................................................. 14 Figure 1.3 Model of olfactory function in wild type and Chd7Gt/+ mice ........................ 15 Figure 1.4 The chromodomain family of proteins contains 9 members that are subdivided into 3 classes on the basis of shared protein motifs. ...................................... 16 Figure 1.5 Model for CHD7 transcriptional regulation .................................................. 17 Figure 2.1 Chd7Gt/+ mice have severely impaired olfaction. ......................................... 64 Figure 2.2 Chd7 is expressed in developing and mature olfactory tissues. ................... 65 Figure 2. 3 Chd7 is expressed in basal stem cells in the mature olfactory epithelium. .. 66 Figure 2.4 Chd7 mutant mice have olfactory bulb hypoplasia ....................................... 67 Figure 2.5 Olfactory sensory neurons and sustentacular cells are physiologically intact in early postnatal Chd7Gt/+ mice ....................................................................................... 68 Figure 2.6 Components of the olfactory cilia are intact in Chd7Gt/+ mice ...................... 69 Figure 2.7 Olfactory sensory neurons in Chd7Gt/+ mutant mice are disorganized and reduced in number............................................................................................................. 70 Figure 2.8 Olfactory epithelial basal cell proliferation is reduced in Chd7Gt/+ mice. ..... 71 viii Figure 2.9 Chd7Gt/+ mice exhibit altered regeneration of olfactory sensory neurons in the olfactory epithelium after chemical ablation. ..................................................................
Load more

Recommended publications
  • Transcriptome-Wide Profiling of Cerebral Cavernous Malformations
    www.nature.com/scientificreports OPEN Transcriptome-wide Profling of Cerebral Cavernous Malformations Patients Reveal Important Long noncoding RNA molecular signatures Santhilal Subhash 2,8, Norman Kalmbach3, Florian Wegner4, Susanne Petri4, Torsten Glomb5, Oliver Dittrich-Breiholz5, Caiquan Huang1, Kiran Kumar Bali6, Wolfram S. Kunz7, Amir Samii1, Helmut Bertalanfy1, Chandrasekhar Kanduri2* & Souvik Kar1,8* Cerebral cavernous malformations (CCMs) are low-fow vascular malformations in the brain associated with recurrent hemorrhage and seizures. The current treatment of CCMs relies solely on surgical intervention. Henceforth, alternative non-invasive therapies are urgently needed to help prevent subsequent hemorrhagic episodes. Long non-coding RNAs (lncRNAs) belong to the class of non-coding RNAs and are known to regulate gene transcription and involved in chromatin remodeling via various mechanism. Despite accumulating evidence demonstrating the role of lncRNAs in cerebrovascular disorders, their identifcation in CCMs pathology remains unknown. The objective of the current study was to identify lncRNAs associated with CCMs pathogenesis using patient cohorts having 10 CCM patients and 4 controls from brain. Executing next generation sequencing, we performed whole transcriptome sequencing (RNA-seq) analysis and identifed 1,967 lncRNAs and 4,928 protein coding genes (PCGs) to be diferentially expressed in CCMs patients. Among these, we selected top 6 diferentially expressed lncRNAs each having signifcant correlative expression with more than 100 diferentially expressed PCGs. The diferential expression status of the top lncRNAs, SMIM25 and LBX2-AS1 in CCMs was further confrmed by qRT-PCR analysis. Additionally, gene set enrichment analysis of correlated PCGs revealed critical pathways related to vascular signaling and important biological processes relevant to CCMs pathophysiology.
    [Show full text]
  • Investigation of the Underlying Hub Genes and Molexular Pathogensis in Gastric Cancer by Integrated Bioinformatic Analyses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Investigation of the underlying hub genes and molexular pathogensis in gastric cancer by integrated bioinformatic analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The high mortality rate of gastric cancer (GC) is in part due to the absence of initial disclosure of its biomarkers. The recognition of important genes associated in GC is therefore recommended to advance clinical prognosis, diagnosis and and treatment outcomes. The current investigation used the microarray dataset GSE113255 RNA seq data from the Gene Expression Omnibus database to diagnose differentially expressed genes (DEGs). Pathway and gene ontology enrichment analyses were performed, and a proteinprotein interaction network, modules, target genes - miRNA regulatory network and target genes - TF regulatory network were constructed and analyzed. Finally, validation of hub genes was performed. The 1008 DEGs identified consisted of 505 up regulated genes and 503 down regulated genes.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Molecular Diagnostic Requisition
    BAYLOR MIRACA GENETICS LABORATORIES SHIP TO: Baylor Miraca Genetics Laboratories 2450 Holcombe, Grand Blvd. -Receiving Dock PHONE: 800-411-GENE | FAX: 713-798-2787 | www.bmgl.com Houston, TX 77021-2024 Phone: 713-798-6555 MOLECULAR DIAGNOSTIC REQUISITION PATIENT INFORMATION SAMPLE INFORMATION NAME: DATE OF COLLECTION: / / LAST NAME FIRST NAME MI MM DD YY HOSPITAL#: ACCESSION#: DATE OF BIRTH: / / GENDER (Please select one): FEMALE MALE MM DD YY SAMPLE TYPE (Please select one): ETHNIC BACKGROUND (Select all that apply): UNKNOWN BLOOD AFRICAN AMERICAN CORD BLOOD ASIAN SKELETAL MUSCLE ASHKENAZIC JEWISH MUSCLE EUROPEAN CAUCASIAN -OR- DNA (Specify Source): HISPANIC NATIVE AMERICAN INDIAN PLACE PATIENT STICKER HERE OTHER JEWISH OTHER (Specify): OTHER (Please specify): REPORTING INFORMATION ADDITIONAL PROFESSIONAL REPORT RECIPIENTS PHYSICIAN: NAME: INSTITUTION: PHONE: FAX: PHONE: FAX: NAME: EMAIL (INTERNATIONAL CLIENT REQUIREMENT): PHONE: FAX: INDICATION FOR STUDY SYMPTOMATIC (Summarize below.): *FAMILIAL MUTATION/VARIANT ANALYSIS: COMPLETE ALL FIELDS BELOW AND ATTACH THE PROBAND'S REPORT. GENE NAME: ASYMPTOMATIC/POSITIVE FAMILY HISTORY: (ATTACH FAMILY HISTORY) MUTATION/UNCLASSIFIED VARIANT: RELATIONSHIP TO PROBAND: THIS INDIVIDUAL IS CURRENTLY: SYMPTOMATIC ASYMPTOMATIC *If family mutation is known, complete the FAMILIAL MUTATION/ VARIANT ANALYSIS section. NAME OF PROBAND: ASYMPTOMATIC/POPULATION SCREENING RELATIONSHIP TO PROBAND: OTHER (Specify clinical findings below): BMGL LAB#: A COPY OF ORIGINAL RESULTS ATTACHED IF PROBAND TESTING WAS PERFORMED AT ANOTHER LAB, CALL TO DISCUSS PRIOR TO SENDING SAMPLE. A POSITIVE CONTROL MAY BE REQUIRED IN SOME CASES. REQUIRED: NEW YORK STATE PHYSICIAN SIGNATURE OF CONSENT I certify that the patient specified above and/or their legal guardian has been informed of the benefits, risks, and limitations of the laboratory test(s) requested.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Beyond Traditional Morphological Characterization of Lung
    Cancers 2020 S1 of S15 Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined Groups Giovanni Centonze, Davide Biganzoli, Natalie Prinzi, Sara Pusceddu, Alessandro Mangogna, Elena Tamborini, Federica Perrone, Adele Busico, Vincenzo Lagano, Laura Cattaneo, Gabriella Sozzi, Luca Roz, Elia Biganzoli and Massimo Milione Table S1. Genes Frequently mutated in Typical Carcinoids (TCs). Mutation Original Entrez Gene Gene Rate % eukaryotic translation initiation factor 1A X-linked [Source: HGNC 4.84 EIF1AX 1964 EIF1AX Symbol; Acc: HGNC: 3250] AT-rich interaction domain 1A [Source: HGNC Symbol;Acc: HGNC: 4.71 ARID1A 8289 ARID1A 11110] LDL receptor related protein 1B [Source: HGNC Symbol; Acc: 4.35 LRP1B 53353 LRP1B HGNC: 6693] 3.53 NF1 4763 NF1 neurofibromin 1 [Source: HGNC Symbol;Acc: HGNC: 7765] DS cell adhesion molecule like 1 [Source: HGNC Symbol; Acc: 2.90 DSCAML1 57453 DSCAML1 HGNC: 14656] 2.90 DST 667 DST dystonin [Source: HGNC Symbol;Acc: HGNC: 1090] FA complementation group D2 [Source: HGNC Symbol; Acc: 2.90 FANCD2 2177 FANCD2 HGNC: 3585] piccolo presynaptic cytomatrix protein [Source: HGNC Symbol; Acc: 2.90 PCLO 27445 PCLO HGNC: 13406] erb-b2 receptor tyrosine kinase 2 [Source: HGNC Symbol; Acc: 2.44 ERBB2 2064 ERBB2 HGNC: 3430] BRCA1 associated protein 1 [Source: HGNC Symbol; Acc: HGNC: 2.35 BAP1 8314 BAP1 950] capicua transcriptional repressor [Source: HGNC Symbol; Acc: 2.35 CIC 23152 CIC HGNC:
    [Show full text]
  • Wnt Signaling in Neural Crest Ontogenesis and Oncogenesis
    cells Review Wnt Signaling in Neural Crest Ontogenesis and Oncogenesis Yu Ji 1,2,3,*, Hongyan Hao 3,4, Kurt Reynolds 1,2,3 , Moira McMahon 2,5 and Chengji J. Zhou 1,2,3,* 1 Department of Biochemistry and Molecular Medicine & Comprehensive Cancer Center, University of California at Davis, School of Medicine, Sacramento, CA 95817, USA; [email protected] 2 Institute for Pediatric Regenerative Medicine, UC Davis School of Medicine and Shriners Hospitals for Children, Sacramento, CA 95817, USA; [email protected] 3 Graduate Program of Biochemistry, Molecular, Cellular and Developmental Biology, University of California, Davis, CA 95616, USA; [email protected] 4 Department of Molecular and Cellular Biology, University of California, Davis, CA 95616, USA 5 College of Letters & Science, University of California, Berkeley, CA 94720, USA * Correspondence: [email protected] (Y.J.); [email protected] (C.J.Z.); Tel.: +1-916-452-2268 (C.J.Z.) Received: 30 August 2019; Accepted: 25 September 2019; Published: 29 September 2019 Abstract: Neural crest (NC) cells are a temporary population of multipotent stem cells that generate a diverse array of cell types, including craniofacial bone and cartilage, smooth muscle cells, melanocytes, and peripheral neurons and glia during embryonic development. Defective neural crest development can cause severe and common structural birth defects, such as craniofacial anomalies and congenital heart disease. In the early vertebrate embryos, NC cells emerge from the dorsal edge of the neural tube during neurulation and then migrate extensively throughout the anterior-posterior body axis to generate numerous derivatives. Wnt signaling plays essential roles in embryonic development and cancer.
    [Show full text]
  • Improving Diagnosis and Treatment of Craniofacial Malformations Utilizing Animal Models
    CHAPTER SEVENTEEN From Bench to Bedside and Back: Improving Diagnosis and Treatment of Craniofacial Malformations Utilizing Animal Models Alice F. Goodwin*,†, Rebecca Kim*,†, Jeffrey O. Bush*,{,},1, Ophir D. Klein*,†,},},1 *Program in Craniofacial Biology, University of California San Francisco, San Francisco, California, USA †Department of Orofacial Sciences, University of California San Francisco, San Francisco, California, USA { Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, California, USA } Department of Pediatrics, University of California San Francisco, San Francisco, California, USA } Institute for Human Genetics, University of California San Francisco, San Francisco, California, USA 1Corresponding authors: e-mail address: [email protected]; [email protected] Contents 1. Models to Uncover Genetics of Cleft Lip and Palate 460 2. Treacher Collins: Proof of Concept of a Nonsurgical Therapeutic for a Craniofacial Syndrome 467 3. RASopathies: Understanding and Developing Treatment for Syndromes of the RAS Pathway 468 4. Craniosynostosis: Pursuing Genetic and Pharmaceutical Alternatives to Surgical Treatment 473 5. XLHED: Developing Treatment Based on Knowledge Gained from Mouse and Canine Models 477 6. Concluding Thoughts 481 Acknowledgments 481 References 481 Abstract Craniofacial anomalies are among the most common birth defects and are associated with increased mortality and, in many cases, the need for lifelong treatment. Over the past few decades, dramatic advances in the surgical and medical care of these patients have led to marked improvements in patient outcomes. However, none of the treat- ments currently in clinical use address the underlying molecular causes of these disor- ders. Fortunately, the field of craniofacial developmental biology provides a strong foundation for improved diagnosis and for therapies that target the genetic causes # Current Topics in Developmental Biology, Volume 115 2015 Elsevier Inc.
    [Show full text]
  • Whole Exome Sequencing in Coloboma/Microphthalmia: Identification of Novel and Recurrent Variants in Seven Genes
    G C A T T A C G G C A T genes Article Whole Exome Sequencing in Coloboma/Microphthalmia: Identification of Novel and Recurrent Variants in Seven Genes Patricia Haug 1 , Samuel Koller 1 , Jordi Maggi 1 , Elena Lang 1,2, Silke Feil 1, Agnès Wlodarczyk 1, Luzy Bähr 1, Katharina Steindl 3, Marianne Rohrbach 4 , Christina Gerth-Kahlert 2,† and Wolfgang Berger 1,5,6,*,† 1 Institute of Medical Molecular Genetics, University of Zurich, 8952 Schlieren, Switzerland; [email protected] (P.H.); [email protected] (S.K.); [email protected] (J.M.); [email protected] (E.L.); [email protected] (S.F.); [email protected] (A.W.); [email protected] (L.B.) 2 Department of Ophthalmology, University Hospital and University of Zurich, 8091 Zurich, Switzerland; [email protected] 3 Institute of Medical Genetics, University of Zurich, 8952 Schlieren, Switzerland; [email protected] 4 Division of Metabolism and Children’s Research Centre, University Children’s Hospital Zurich, 8032 Zurich, Switzerland; [email protected] 5 Neuroscience Center Zurich (ZNZ), University and ETH Zurich, 8006 Zurich, Switzerland 6 Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, 8006 Zurich, Switzerland * Correspondence: [email protected] † Both authors contributed equally to this work. Abstract: Coloboma and microphthalmia (C/M) are related congenital eye malformations, which can cause significant visual impairment. Molecular diagnosis is challenging as the genes associated to date with C/M account for only a small percentage of cases. Overall, the genetic cause remains unknown in up to 80% of patients.
    [Show full text]
  • Directed Differentiation of Human Embryonic Stem Cells Into Haematopoietic and Definitive Endodermal Lineages
    DIRECTED DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS INTO HAEMATOPOIETIC AND DEFINITIVE ENDODERMAL LINEAGES ABRAHAM SUMAN MARY (M.Sc MICROBIOLOGY, UNIV. OF MUMBAI, INDIA) A THESIS SUBMITTED FOR THE DEGREE OF MASTER OF SCIENCE DEPARTMENT OF BIOCHEMISTRY NATIONAL UNIVERSITY OF SINGAPORE 2009 ACKNOWLEDGEMENTS In all things I give YOU glory! You have always led me through amazing paths and given me gifts that I don’t deserve. I thank you Lord for all the blessings you constantly shower on me. Everything is possible with God! I thank Dr. Alan Colman for being my guide and helping me to initiate the work contained in this dissertation. His support and encouragement have been invaluable. Thank you, Alan for your support through the years. Dr. Norris Ray Dunn took me under his wing and guided me through this endeavour. He has been a true mentor, always willing to teach, and I have learned a lot from him. Ray, thank you for showing me the way and helping me reach this juncture. A significant part of the research was conducted at ES Cell International Pte Ltd to whom I would like to express my sincere gratitude. Triona, Jacqui, Robert, Michael, Bruce, Chirag, Suzan and so many others have played important roles and encouraged me at all times. Critical portions of this work were done at the Institute of Medical Biology, A*Star. I would like to register my appreciation for the support and help provided by many people in IMB especially, members of the Ray Dunn lab, Mike Jones lab and Alan Colman lab. Kee Yew, thank you for giving me your precious time and helping me with some of the most important data in this dissertation.
    [Show full text]
  • Genome-Wide Mapping in a House Mouse Hybrid Zone Reveals Hybrid Sterility Loci and Dobzhansky-Muller Interactions Leslie M Turner1,2, Bettina Harr1*
    RESEARCH ARTICLE elifesciences.org Genome-wide mapping in a house mouse hybrid zone reveals hybrid sterility loci and Dobzhansky-Muller interactions Leslie M Turner1,2, Bettina Harr1* 1Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Biology, Plön, Germany; 2Laboratory of Genetics, University of Wisconsin, Madison, United States Abstract Mapping hybrid defects in contact zones between incipient species can identify genomic regions contributing to reproductive isolation and reveal genetic mechanisms of speciation. The house mouse features a rare combination of sophisticated genetic tools and natural hybrid zones between subspecies. Male hybrids often show reduced fertility, a common reproductive barrier between incipient species. Laboratory crosses have identified sterility loci, but each encompasses hundreds of genes. We map genetic determinants of testis weight and testis gene expression using offspring of mice captured in a hybrid zone between M. musculus musculus and M. m. domesticus. Many generations of admixture enables high-resolution mapping of loci contributing to these sterility-related phenotypes. We identify complex interactions among sterility loci, suggesting multiple, non-independent genetic incompatibilities contribute to barriers to gene flow in the hybrid zone. DOI: 10.7554/eLife.02504.001 Introduction *For correspondence: harr@ New species arise when reproductive barriers form, preventing gene flow between populations evolbio.mpg.de (Coyne and Orr, 2004). Recently, two approaches have substantially
    [Show full text]
  • An Intronic Variant of CHD7 Identi Ed in Autism Patients Interferes With
    An Intronic Variant of CHD7 Identied in Autism Patients Interferes With Neuronal Differentiation and Development Ran Zhang Institute of Neuroscience Chinese Academy of Sciences Hui He Institute of Neuroscience Chinese Academy of Sciences Bo Yuan Institute of Neuroscience Chinese Academy of Sciences Ziyan Wu Institute of Neuroscience Chinese Academy of Sciences Xiuzhen Wang Institute of Neuroscience Chinese Academy of Sciences Yasong Du Shanghai Mental Health Center Yuejun Chen Institute of Neuroscience Chinese Academy of Sciences Zilong Qiu ( [email protected] ) Institute of Neuroscience, Chinese Academy of Sciences https://orcid.org/0000-0003-4286-3288 Research Keywords: Autism, CHD7, Intronic variant, Inherited variant Posted Date: August 17th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-58118/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published at Neuroscience Bulletin on May 4th, 2021. See the published version at https://doi.org/10.1007/s12264-021-00685-w. Page 1/27 Abstract Background: Genetic compositions play critical roles in pathogenesis of autism spectrum disorders (ASD). Inherited and de novo intronic variants are often seen in patients with ASD. However, the biological signicance of intronic variants are dicult to address. Here, we identied a recurrent inherited intronic variant in the CHD7 gene among Chinese ASD cohort, which is specically enriched in East Asian populations. CHD7 has been implicated in numerous developmental disorders including CHARGE syndrome and ASD. Here, we use differentiated human embryonic stem cells to investigate whether the ASD-associated CHD7 intronic variant may affect neural development.
    [Show full text]